Filing Details

Accession Number:
0001179110-20-004928
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-17 16:03:08
Reporting Period:
2017-04-16
Accepted Time:
2020-04-17 16:03:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1417243 R. Gabriel Cappucci C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
Senior Vp, Controller And Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-16 2,734 $9.60 6,077 No 4 M Direct
Common Stock Acquisiton 2020-04-16 2,355 $12.21 8,432 No 4 M Direct
Common Stock Acquisiton 2020-04-16 14,850 $22.30 23,282 No 4 M Direct
Common Stock Disposition 2020-04-16 19,939 $169.16 3,343 No 4 S Direct
Common Stock Disposition 2020-04-16 2,355 $165.93 988 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-04-16 2,734 $0.00 2,734 $9.60
Common Stock Employee Stock Option (right to buy) Disposition 2020-04-16 2,355 $0.00 2,355 $12.21
Common Stock Employee Stock Option (right to buy) Disposition 2020-04-16 14,850 $0.00 14,850 $22.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-04-22 No 4 M Direct
0 2026-03-07 No 4 M Direct
4,950 2027-03-03 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 2, 2020.
  2. Represents the weighted average price of transactions ranging from $166.05 to $171.55. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The option vested as to 25% of the shares on April 22, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.
  4. The option vested as to 25% of the shares on March 7, 2017. The remainder of the shares vested in 36 equal monthly installments thereafter.
  5. The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.